Maekawa Masato, Nagaoka Tomonori, Taniguchi Terumi, Higashi Hitomi, Sugimura Haruhiko, Sugano Kokichi, Yonekawa Hiroyuki, Satoh Takatomo, Horii Toshinobu, Shirai Naohito, Takeshita Akihiro, Kanno Takashi
Department of Laboratory Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Clin Chem. 2004 Aug;50(8):1322-7. doi: 10.1373/clinchem.2004.032060. Epub 2004 Jun 3.
We developed a rapid, precise, and accurate microarray-based method that uses a three-dimensional platform for detection of mutations.
We used the PamChip microarray to detect mutations in codons 12 and 13 of K-ras in 15 cell lines and 81 gastric or colorectal cancer tissues. Fluorescein isothiocyanate-labeled PCR products were analyzed with the microarray. We confirmed the microarray results with PCR-single-strand conformation polymorphism (SSCP) analysis and DNA sequencing.
We could correctly identify wild-type, heterozygous, and homozygous mutant genotypes with the PamChip microarray in <3.5 h. The array data were consistent with those of PCR-SSCP analysis and DNA sequencing. All 15 cell lines and 80 of 81 clinical cancer specimens (98.8%; 95% confidence interval, 96.4-100%) were genotyped accurately with the microarray, a rate better than that of direct DNA sequencing (38.9%) or SSCP (93.8%). Only one clinical specimen was misdiagnosed as homozygous for the wild-type allele. Densitometric analysis of SSCP bands indicated that the content of the mutant allele in the specimen was approximately 16%. The PamChip microarray could detect mutant alleles representing more than 25% of the SSCP band proportions. Therefore, the limit for detection of mutant alleles by the PamChip microarray was estimated to be 16-25% of the total DNA.
The PamChip microarray is a novel three-dimensional microarray system and can be used to analyze K-ras mutations quickly and accurately. The mutation detection rate was nearly 100% and was similar to that of PCR-SSCP together with sequencing analysis, but the microarray analysis was faster and easier.
我们开发了一种基于微阵列的快速、精确且准确的方法,该方法使用三维平台来检测突变。
我们使用PamChip微阵列检测15种细胞系以及81份胃癌或结直肠癌组织中K-ras基因第12和13密码子的突变。用该微阵列分析异硫氰酸荧光素标记的PCR产物。我们通过PCR-单链构象多态性(SSCP)分析和DNA测序来确认微阵列结果。
我们能够在不到3.5小时内用PamChip微阵列正确鉴定野生型、杂合型和纯合突变型基因型。阵列数据与PCR-SSCP分析和DNA测序的数据一致。所有15种细胞系以及81份临床癌症标本中的80份(98.8%;95%置信区间,96.4 - 100%)通过微阵列准确进行了基因分型,这一比率优于直接DNA测序(38.9%)或SSCP(93.8%)。只有一份临床标本被误诊为野生型等位基因纯合子。SSCP条带的光密度分析表明该标本中突变等位基因的含量约为16%。PamChip微阵列能够检测到占SSCP条带比例超过25%的突变等位基因。因此,PamChip微阵列检测突变等位基因的限度估计为总DNA的16% - 25%。
PamChip微阵列是一种新型的三维微阵列系统,可用于快速准确地分析K-ras突变。突变检测率接近100%,与PCR-SSCP及测序分析相似,但微阵列分析更快且更简便。